Sign In
Buy BBH
$205.55
-2.46 (-1.18%)
At Close: Jul 31, 2026
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis
02:18pm, Tuesday, 12'th Jan 2021
The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.
ETFs to Tap AstraZeneca Mega-Deal to Buy Alexion
11:17am, Tuesday, 15'th Dec 2020
AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.
3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover
08:29am, Monday, 14'th Dec 2020
The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when AstraZeneca (NYSE: AZN) announced a $39-billion takeover of Alexi
How Will Vaccine Arrivals Affect Biotech ETFs?
04:17pm, Monday, 30'th Nov 2020
November has been a big month for stock and biotech ETFs, and with the Federal Aviation Administration announcing that it supported the “first mass air shipment” of coronavirus vaccines on Friday,
Bullish on Biotech? The BBH ETF is Not Just a 2020 Play
12:04pm, Thursday, 19'th Nov 2020
The COVID-19 pandemic has given way to new technological innovations in the biotechnology sector with respect to creating a vaccine. ETF investors looking for a play that can take them well into 2021
Will Moderna Vaccine News Boost Biotech ETFs?
03:30pm, Thursday, 12'th Nov 2020
Monday saw stocks and index ETFs surge, after the announcement from Pfizer that the pharmaceutical giant had a vaccine candidate with an over 90% effectiveness in clinical trials. Now another biotech,
Can't Get Enough Biotech Exposure in Your Portfolio?
12:38pm, Thursday, 29'th Oct 2020
As coronavirus cases start to tick upwards once more, the race to create a vaccine will only intensify, boding well for the biotechnology sector. ETF investors may want to keep an eye on biotech funds
Biotech ETFs at multi-week highs, extending winning streak
01:45pm, Tuesday, 27'th Oct 2020
Biotechnology exchange-traded funds outperformed Tuesday as investors focused on next-generation solutions to the coronavirus and more. The ARK Genomic Revolution ETF was up 2.2% in the early afternoo
Is COVID-19 An Impetus For ESG Investing?
07:00am, Wednesday, 02'nd Sep 2020
The primary driver of doing ESG is risk mitigation and COVID-19 pushed environmental and societal issues higher up the risk spectrum.
Another Round of Coronavirus Cases Puts This Biotech ETF in Focus
04:45pm, Monday, 29'th Jun 2020
Already one of the ETFs at the center of the coronavirus investment thesis, the ALPS Medical Breakthroughs ETF (SBIO) could be poised for more upside
The Reopening Killed The V-Shaped Recovery
07:43am, Monday, 29'th Jun 2020
This is a weekly series focused on analyzing the previous week’s economic data releases. The objective is to concentrate on leading indicators of economic activ
New Pharma ETF Focuses on Testing and Treatment for Infectious Diseases--but Not Covid-19
08:51pm, Sunday, 28'th Jun 2020
GERM offers investors exposure to established providers and ‘unsung heroes’ of biotech and life sciences Continue reading...
A Healthcare ETF Could Benefit From Index Reshuffling | ETF Trends
05:16pm, Tuesday, 23'rd Jun 2020
On Friday, FTSE Russell, one of the largest providers of benchmarks used by providers of index funds and ETFs
Biogen and Moderna shares show how biotech ETFs may look similar but act differently
07:14pm, Thursday, 18'th Jun 2020
Big shares of a losing biotech stock didn’t stop a pair of four-star-rated ETFs from moving higher Thursday. They may sound similar, but hold distinct...
Biotech ETFs: Appraising The Pipelines
12:00am, Wednesday, 17'th Jun 2020
Parsing the performance and holdings of different biotech funds.
